XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.8.0.1

STOCK-BASED COMPENSATION | 3 Months Ended
--- | ---
Jan. 28, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION The Company issues stock options and nonvested shares as part of its stock incentive plans for employees and non-employee directors. The Company’s policy is to grant options with the exercise price equal to the market price of the common stock on the date of grant. Options typically vest over four years and expire ten years after the date of the grant. The Company recognizes stock-based compensation expense ratably over the shorter of the requisite service period or vesting period. The fair value of stock-based compensation granted to retirement-eligible individuals is expensed at the time of grant. A reconciliation of the number of options outstanding and exercisable (in thousands) as of January 28, 2018, and changes during the quarter then ended, is as follows:
| Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding at October 29, 2017 | 30,685 |  |  | $ | 18.08 |  |  |  |  |
Granted | 1,968 |  |  | 37.10 |  |  |  |  |
Exercised | 2,301 |  |  | 10.20 |  |  |  |  |
Forfeited | 3 |  |  | 33.31 |  |  |  |  |
Expired | 1 |  |  | 37.76 |  |  |  |  |
Outstanding at January 28, 2018 | 30,348 |  |  | $ | 19.91 |  |  | 5.0 |  | $ | 460,530 |
Exercisable at January 28, 2018 | 24,284 |  |  | $ | 16.34 |  |  | 4.1 |  | $ | 448,268 |
The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised (in thousands) during the first quarter of fiscal years 2018 and 2017, are as follows.
| Three Months Ended |
| January 28, 2018 |  | January 29, 2017 |
Weighted-average grant date fair value | $ | 6.93 |  |  | $ | 6.33 |  |
Intrinsic value of exercised options | $ | 56,302 |  |  | $ | 51,942 |  |
The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:
| Three Months Ended |
| January 28, 2018 |  | January 29, 2017 |
Risk-free interest rate | 2.3 | % |  | 2.4 | % |
Dividend yield | 2.0 | % |  | 2.0 | % |
Stock price volatility | 19.0 | % |  | 19.0 | % |
Expected option life | 8 years |  |  | 8 years |  |
As part of the annual valuation process, the Company reassesses the appropriateness of the inputs used in the valuation models. The Company establishes the risk-free interest rate using stripped U.S. Treasury yields as of the grant date where the remaining term is approximately the expected life of the option. The dividend yield is set based on the dividend rate approved by the Company’s Board of Directors and the stock price on the grant date. The expected volatility assumption is set based primarily on historical volatility. As a reasonableness test, implied volatility from exchange traded options is also examined to validate the volatility range obtained from the historical analysis. The expected life assumption is set based on an analysis of past exercise behavior by option holders. In performing the valuations for option grants, the Company has not stratified option holders as exercise behavior has historically been consistent across all executive employee and non-employee director groups. Nonvested shares vest on the earlier of the day before the Company’s next annual meeting date or one year from grant date. Subsequent to the end of the quarter, restricted shares were awarded with a restricted period expiring the date of the Company’s next annual stockholders meeting. A reconciliation of the nonvested shares (in thousands) as of January 28, 2018, and changes during the quarter then ended, is as follows:
| Shares |  | Weighted- Average Grant- Date Fair Value
Nonvested at October 29, 2017 | 58 |  |  | $ | 35.62 |
Granted | — |  |  | — |
Vested | 3 |  |  | 35.62 |
Forfeited | 1 |  |  | 35.62 |
Nonvested at January 28, 2018 | 54 |  |  | $ | 35.62 |
The weighted-average grant date fair value of nonvested shares granted, the total fair value (in thousands) of nonvested shares granted, and the fair value (in thousands) of shares that have vested during the first quarter of fiscal years 2018 and 2017, are as follows:
| Three Months Ended
| January 28, 2018 |  | January 29, 2017
Weighted-average grant date fair value | $ | 35.62 |  |  | $ | 41.01 |
Fair value of nonvested shares granted | — |  |  | 1,920 |
Fair value of shares vested | 133 |  |  | 1,920 |
During the first quarter ended January 28, 2018, stock-based compensation expense was $7.3 million compared to $7.2 million for the first quarter ended January 29, 2017. At January 28, 2018, there was $17.7 million of total unrecognized compensation expense from stock-based compensation arrangements granted under the plans. This compensation is expected to be recognized over a weighted-average period of approximately 2.6 years. During the first quarter ended January 28, 2018, cash received from stock option exercises was $23.5 million compared to $7.4 million for the first quarter ended January 29, 2017. Shares issued for option exercises and nonvested shares may be either authorized but unissued shares, or shares of treasury stock acquired in the open market or otherwise.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration